Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1009307-39-4

Post Buying Request

1009307-39-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1009307-39-4 Usage

Description

2-(2-bromo-1,1,2,2-d4-ethyl)-isoindole-1,3-dione, also known as N-(2-Bromoethyl-d4)phthalimide, is a labeled analogue of N-(2-Bromoethyl)phthalimide (B683975). It is a building block used in the synthesis of various compounds, including β-Cyclodextrin derivatives and pharmaceuticals.

Uses

Used in Pharmaceutical Industry:
2-(2-bromo-1,1,2,2-d4-ethyl)-isoindole-1,3-dione is used as an intermediate in the synthesis of (E)-Fluvoxamine-d4 Maleate (F603503), the labeled analogue of (E)-Fluvoxamine Maleate (F603500). 2-(2-bromo-1,1,2,2-d4-ethyl)-isoindole-1,3-dione is a selective serotonin reuptake inhibitor (SSRI) used as an anti-depressant and antiobsessional medication.
Additionally, it serves as a reactant for the preparation of β-Cyclodextrin derivatives, which have potential applications in various fields, including drug delivery and supramolecular chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 1009307-39-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,3,0 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1009307-39:
(9*1)+(8*0)+(7*0)+(6*9)+(5*3)+(4*0)+(3*7)+(2*3)+(1*9)=114
114 % 10 = 4
So 1009307-39-4 is a valid CAS Registry Number.

1009307-39-4Downstream Products

1009307-39-4Relevant articles and documents

4-Aminoquinazoline derivatives and methods of use thereof

-

Page/Page column 18, (2008/06/13)

This invention relates to novel 4-aminoquinazolines, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering inhibitors of the EGFR and HER-2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1009307-39-4